NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 3.180
-0.160 (-4.79%)
At close: Jan 9, 2026
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €366.73 million as of January 9, 2026. Its market cap has increased by 381.26% in one year.
Market Cap
366.73M
Enterprise Value
173.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.18
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 366.73M, an increase of 194.68%. That is a compound annual growth rate of 19.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 366.73M | -6.16% |
| Dec 31, 2025 | 390.81M | 484.53% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.49B |
| Deutsche Bank Aktiengesellschaft | 63.01B |